decor-right

Scientific Publications

Epitope Discovery for Genomes (EDGE™) Platform

Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification.

Nature Biotechnology (Dec 2018)

GRANITE (Individualized Neoantigen Program) Phase 1/2 Study

Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results.

Nature Medicine (Aug 2022)

CORAL (COVID-19 Program) Preclinical Study

Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection.

Nature Communications (June 2022)

MHC class II antigen identification for cancer immunotherapy by deep learning on tumor HLA peptides.

American Association for Cancer Research 2019 (AACR 2019, abstract 4445)

Identification and Validation of Shared Neoantigens for Cancer Immunotherapy.

Society for Immunotherapy of Cancer 2019 (SITC 2019: abstract P731)

Antigen identification for cancer immunotherapy by deep learning on tumor HLA peptides.

American Association for Cancer Research 2018 (AACR 2018, abstract 5722)

Top